Altre lingue Aptevo Therapeutics Inc.

Azioni

APVO

US03835L3069

Mercato chiuso - Nasdaq Altri mercati azionari 21:59:50 05/03/2024			Variaz. 5gg	Var. 1 gen.
5,694 ^USD	-7,17%		-13,10%	-28,51%

11/04	I mercati azionari statunitensi chiudono misti dopo i dati sull'inflazione dei prezzi alla produzione di marzo	MT
11/04	Top Midday Decliners	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering	16/04
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering	12/04
US Equity Markets Close Mixed After March Producer Price Inflation Data	11/04
Top Midday Decliners	11/04
Top Premarket Decliners	11/04
Aptevo Therapeutics Inc. Provides Pipeline Update	10/04
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4	07/03
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4	07/03
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update	06/03
Aptevo Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Alligator Bioscience AB reports full year financial results for 2023 and for Q4 2023 and provides a business update	08/02
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update	15/11
Aptevo Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Certain Warrants of Aptevo Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 3-NOV-2023.	03/11
Certain Stock Options of Aptevo Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 3-NOV-2023.	03/11
Certain Common Stock of Aptevo Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 3-NOV-2023.	03/11
Aptevo to Present at Bio-Europe Conference	02/11
Aptevo Therapeutics : 28 August 2023 Investor Presentation	28/08/23
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update	11/08/23
Aptevo Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Aptevo Therapeutics Inc.

Azioni

APVO

US03835L3069

Altre lingue

Filtri